289 related articles for article (PubMed ID: 7622422)
1. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
2. Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines.
Sillem M; Prifti S; Koumouridis A; Runnebaum B
Eur J Gynaecol Oncol; 1999; 20(5-6):367-70. PubMed ID: 10609496
[TBL] [Abstract][Full Text] [Related]
3. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
4. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
[TBL] [Abstract][Full Text] [Related]
5. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
6. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
7. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
8. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract][Full Text] [Related]
10. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F
Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.
Keski-Oja J; Lohi J; Tuuttila A; Tryggvason K; Vartio T
Exp Cell Res; 1992 Oct; 202(2):471-6. PubMed ID: 1397099
[TBL] [Abstract][Full Text] [Related]
12. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
14. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines.
Koshikawa N; Yasumitsu H; Umeda M; Miyazaki K
Cancer Res; 1992 Sep; 52(18):5046-53. PubMed ID: 1387587
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
[TBL] [Abstract][Full Text] [Related]
16. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
Testa JE
Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
[TBL] [Abstract][Full Text] [Related]
17. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
Takagi M
Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 promotes proteolytic activity of ovarian carcinoma.
Rosanò L; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():306S-309S. PubMed ID: 12193110
[TBL] [Abstract][Full Text] [Related]
20. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
